img

Global Rare Disease Drug Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Rare Disease Drug Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Rare Disease Drug report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Rare Disease Drug market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Hospital Pharmacies and Speciality Pharmacies are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Rare Disease Drug industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Rare Disease Drug key manufacturers include Novartis AG, Bristol-Myers Squibb Company, Celgene Corporation, F. Hoffmann-La Roche Ltd., Pfizer, Inc., Sanofi S.A., Alexion Pharmaceuticals, Inc., Eli Lilly and Company and Novo Nordisk A/S, etc. Novartis AG, Bristol-Myers Squibb Company, Celgene Corporation are top 3 players and held % sales share in total in 2022.
Rare Disease Drug can be divided into Above 1‰, 0.65‰～1‰ and Below 0.1‰,, etc. Above 1‰ is the mainstream product in the market, accounting for % sales share globally in 2022.
Rare Disease Drug is widely used in various fields, such as Hospital Pharmacies, Speciality Pharmacies, Retail pharmacies and Others, etc. Hospital Pharmacies provides greatest supports to the Rare Disease Drug industry development. In 2022, global % sales of Rare Disease Drug went into Hospital Pharmacies filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Rare Disease Drug market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Novartis AG
Bristol-Myers Squibb Company
Celgene Corporation
F. Hoffmann-La Roche Ltd.
Pfizer, Inc.
Sanofi S.A.
Alexion Pharmaceuticals, Inc.
Eli Lilly and Company
Novo Nordisk A/S
AstraZeneca
Eisai Co., Ltd.
Daiichi Sankyo Company Limited
Bayer AG
GlaxoSmithKline
Merck & Co., Inc.
Johnson & Johnson
Biogen, Inc.
Takeda
Amgen, Inc.
Deciphera
Atara Biotherapeutics
ProQR
Segment by Type
Above 1‰
0.65‰～1‰
Below 0.1‰

Segment by Application


Hospital Pharmacies
Speciality Pharmacies
Retail pharmacies
Others

Segment by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Rare Disease Drug market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Rare Disease Drug, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Rare Disease Drug industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Rare Disease Drug in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Rare Disease Drug introduction, etc. Rare Disease Drug Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Rare Disease Drug market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.

Table of Content

1 Rare Disease Drug Market Overview
1.1 Rare Disease Drug Product Overview
1.2 Rare Disease Drug Market Segment by Type
1.2.1 Above 1‰
1.2.2 0.65‰～1‰
1.2.3 Below 0.1‰
1.3 Global Rare Disease Drug Market Size by Type
1.3.1 Global Rare Disease Drug Market Size Overview by Type (2018-2034)
1.3.2 Global Rare Disease Drug Historic Market Size Review by Type (2018-2024)
1.3.3 Global Rare Disease Drug Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Rare Disease Drug Sales Breakdown by Type (2018-2024)
1.4.2 Europe Rare Disease Drug Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Rare Disease Drug Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Rare Disease Drug Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Rare Disease Drug Sales Breakdown by Type (2018-2024)
2 Global Rare Disease Drug Market Competition by Company
2.1 Global Top Players by Rare Disease Drug Sales (2018-2024)
2.2 Global Top Players by Rare Disease Drug Revenue (2018-2024)
2.3 Global Top Players by Rare Disease Drug Price (2018-2024)
2.4 Global Top Manufacturers Rare Disease Drug Manufacturing Base Distribution, Sales Area, Product Type
2.5 Rare Disease Drug Market Competitive Situation and Trends
2.5.1 Rare Disease Drug Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Rare Disease Drug Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Rare Disease Drug as of 2022)
2.7 Date of Key Manufacturers Enter into Rare Disease Drug Market
2.8 Key Manufacturers Rare Disease Drug Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Rare Disease Drug Status and Outlook by Region
3.1 Global Rare Disease Drug Market Size and CAGR by Region: 2018 VS 2022 VS 2034
3.2 Global Rare Disease Drug Historic Market Size by Region
3.2.1 Global Rare Disease Drug Sales in Volume by Region (2018-2024)
3.2.2 Global Rare Disease Drug Sales in Value by Region (2018-2024)
3.2.3 Global Rare Disease Drug Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Rare Disease Drug Forecasted Market Size by Region
3.3.1 Global Rare Disease Drug Sales in Volume by Region (2024-2034)
3.3.2 Global Rare Disease Drug Sales in Value by Region (2024-2034)
3.3.3 Global Rare Disease Drug Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Rare Disease Drug by Application
4.1 Rare Disease Drug Market Segment by Application
4.1.1 Hospital Pharmacies
4.1.2 Speciality Pharmacies
4.1.3 Retail pharmacies
4.1.4 Others
4.2 Global Rare Disease Drug Market Size by Application
4.2.1 Global Rare Disease Drug Market Size Overview by Application (2018-2034)
4.2.2 Global Rare Disease Drug Historic Market Size Review by Application (2018-2024)
4.2.3 Global Rare Disease Drug Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Rare Disease Drug Sales Breakdown by Application (2018-2024)
4.3.2 Europe Rare Disease Drug Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Rare Disease Drug Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Rare Disease Drug Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Rare Disease Drug Sales Breakdown by Application (2018-2024)
5 North America Rare Disease Drug by Country
5.1 North America Rare Disease Drug Historic Market Size by Country
5.1.1 North America Rare Disease Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
5.1.2 North America Rare Disease Drug Sales in Volume by Country (2018-2024)
5.1.3 North America Rare Disease Drug Sales in Value by Country (2018-2024)
5.2 North America Rare Disease Drug Forecasted Market Size by Country
5.2.1 North America Rare Disease Drug Sales in Volume by Country (2024-2034)
5.2.2 North America Rare Disease Drug Sales in Value by Country (2024-2034)
6 Europe Rare Disease Drug by Country
6.1 Europe Rare Disease Drug Historic Market Size by Country
6.1.1 Europe Rare Disease Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
6.1.2 Europe Rare Disease Drug Sales in Volume by Country (2018-2024)
6.1.3 Europe Rare Disease Drug Sales in Value by Country (2018-2024)
6.2 Europe Rare Disease Drug Forecasted Market Size by Country
6.2.1 Europe Rare Disease Drug Sales in Volume by Country (2024-2034)
6.2.2 Europe Rare Disease Drug Sales in Value by Country (2024-2034)
7 Asia-Pacific Rare Disease Drug by Region
7.1 Asia-Pacific Rare Disease Drug Historic Market Size by Region
7.1.1 Asia-Pacific Rare Disease Drug Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2034
7.1.2 Asia-Pacific Rare Disease Drug Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Rare Disease Drug Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Rare Disease Drug Forecasted Market Size by Region
7.2.1 Asia-Pacific Rare Disease Drug Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Rare Disease Drug Sales in Value by Region (2024-2034)
8 Latin America Rare Disease Drug by Country
8.1 Latin America Rare Disease Drug Historic Market Size by Country
8.1.1 Latin America Rare Disease Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
8.1.2 Latin America Rare Disease Drug Sales in Volume by Country (2018-2024)
8.1.3 Latin America Rare Disease Drug Sales in Value by Country (2018-2024)
8.2 Latin America Rare Disease Drug Forecasted Market Size by Country
8.2.1 Latin America Rare Disease Drug Sales in Volume by Country (2024-2034)
8.2.2 Latin America Rare Disease Drug Sales in Value by Country (2024-2034)
9 Middle East and Africa Rare Disease Drug by Country
9.1 Middle East and Africa Rare Disease Drug Historic Market Size by Country
9.1.1 Middle East and Africa Rare Disease Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
9.1.2 Middle East and Africa Rare Disease Drug Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Rare Disease Drug Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Rare Disease Drug Forecasted Market Size by Country
9.2.1 Middle East and Africa Rare Disease Drug Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Rare Disease Drug Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Novartis AG
10.1.1 Novartis AG Company Information
10.1.2 Novartis AG Introduction and Business Overview
10.1.3 Novartis AG Rare Disease Drug Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Novartis AG Rare Disease Drug Products Offered
10.1.5 Novartis AG Recent Development
10.2 Bristol-Myers Squibb Company
10.2.1 Bristol-Myers Squibb Company Company Information
10.2.2 Bristol-Myers Squibb Company Introduction and Business Overview
10.2.3 Bristol-Myers Squibb Company Rare Disease Drug Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Bristol-Myers Squibb Company Rare Disease Drug Products Offered
10.2.5 Bristol-Myers Squibb Company Recent Development
10.3 Celgene Corporation
10.3.1 Celgene Corporation Company Information
10.3.2 Celgene Corporation Introduction and Business Overview
10.3.3 Celgene Corporation Rare Disease Drug Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Celgene Corporation Rare Disease Drug Products Offered
10.3.5 Celgene Corporation Recent Development
10.4 F. Hoffmann-La Roche Ltd.
10.4.1 F. Hoffmann-La Roche Ltd. Company Information
10.4.2 F. Hoffmann-La Roche Ltd. Introduction and Business Overview
10.4.3 F. Hoffmann-La Roche Ltd. Rare Disease Drug Sales, Revenue and Gross Margin (2018-2024)
10.4.4 F. Hoffmann-La Roche Ltd. Rare Disease Drug Products Offered
10.4.5 F. Hoffmann-La Roche Ltd. Recent Development
10.5 Pfizer, Inc.
10.5.1 Pfizer, Inc. Company Information
10.5.2 Pfizer, Inc. Introduction and Business Overview
10.5.3 Pfizer, Inc. Rare Disease Drug Sales, Revenue and Gross Margin (2018-2024)
10.5.4 Pfizer, Inc. Rare Disease Drug Products Offered
10.5.5 Pfizer, Inc. Recent Development
10.6 Sanofi S.A.
10.6.1 Sanofi S.A. Company Information
10.6.2 Sanofi S.A. Introduction and Business Overview
10.6.3 Sanofi S.A. Rare Disease Drug Sales, Revenue and Gross Margin (2018-2024)
10.6.4 Sanofi S.A. Rare Disease Drug Products Offered
10.6.5 Sanofi S.A. Recent Development
10.7 Alexion Pharmaceuticals, Inc.
10.7.1 Alexion Pharmaceuticals, Inc. Company Information
10.7.2 Alexion Pharmaceuticals, Inc. Introduction and Business Overview
10.7.3 Alexion Pharmaceuticals, Inc. Rare Disease Drug Sales, Revenue and Gross Margin (2018-2024)
10.7.4 Alexion Pharmaceuticals, Inc. Rare Disease Drug Products Offered
10.7.5 Alexion Pharmaceuticals, Inc. Recent Development
10.8 Eli Lilly and Company
10.8.1 Eli Lilly and Company Company Information
10.8.2 Eli Lilly and Company Introduction and Business Overview
10.8.3 Eli Lilly and Company Rare Disease Drug Sales, Revenue and Gross Margin (2018-2024)
10.8.4 Eli Lilly and Company Rare Disease Drug Products Offered
10.8.5 Eli Lilly and Company Recent Development
10.9 Novo Nordisk A/S
10.9.1 Novo Nordisk A/S Company Information
10.9.2 Novo Nordisk A/S Introduction and Business Overview
10.9.3 Novo Nordisk A/S Rare Disease Drug Sales, Revenue and Gross Margin (2018-2024)
10.9.4 Novo Nordisk A/S Rare Disease Drug Products Offered
10.9.5 Novo Nordisk A/S Recent Development
10.10 AstraZeneca
10.10.1 AstraZeneca Company Information
10.10.2 AstraZeneca Introduction and Business Overview
10.10.3 AstraZeneca Rare Disease Drug Sales, Revenue and Gross Margin (2018-2024)
10.10.4 AstraZeneca Rare Disease Drug Products Offered
10.10.5 AstraZeneca Recent Development
10.11 Eisai Co., Ltd.
10.11.1 Eisai Co., Ltd. Company Information
10.11.2 Eisai Co., Ltd. Introduction and Business Overview
10.11.3 Eisai Co., Ltd. Rare Disease Drug Sales, Revenue and Gross Margin (2018-2024)
10.11.4 Eisai Co., Ltd. Rare Disease Drug Products Offered
10.11.5 Eisai Co., Ltd. Recent Development
10.12 Daiichi Sankyo Company Limited
10.12.1 Daiichi Sankyo Company Limited Company Information
10.12.2 Daiichi Sankyo Company Limited Introduction and Business Overview
10.12.3 Daiichi Sankyo Company Limited Rare Disease Drug Sales, Revenue and Gross Margin (2018-2024)
10.12.4 Daiichi Sankyo Company Limited Rare Disease Drug Products Offered
10.12.5 Daiichi Sankyo Company Limited Recent Development
10.13 Bayer AG
10.13.1 Bayer AG Company Information
10.13.2 Bayer AG Introduction and Business Overview
10.13.3 Bayer AG Rare Disease Drug Sales, Revenue and Gross Margin (2018-2024)
10.13.4 Bayer AG Rare Disease Drug Products Offered
10.13.5 Bayer AG Recent Development
10.14 GlaxoSmithKline
10.14.1 GlaxoSmithKline Company Information
10.14.2 GlaxoSmithKline Introduction and Business Overview
10.14.3 GlaxoSmithKline Rare Disease Drug Sales, Revenue and Gross Margin (2018-2024)
10.14.4 GlaxoSmithKline Rare Disease Drug Products Offered
10.14.5 GlaxoSmithKline Recent Development
10.15 Merck & Co., Inc.
10.15.1 Merck & Co., Inc. Company Information
10.15.2 Merck & Co., Inc. Introduction and Business Overview
10.15.3 Merck & Co., Inc. Rare Disease Drug Sales, Revenue and Gross Margin (2018-2024)
10.15.4 Merck & Co., Inc. Rare Disease Drug Products Offered
10.15.5 Merck & Co., Inc. Recent Development
10.16 Johnson & Johnson
10.16.1 Johnson & Johnson Company Information
10.16.2 Johnson & Johnson Introduction and Business Overview
10.16.3 Johnson & Johnson Rare Disease Drug Sales, Revenue and Gross Margin (2018-2024)
10.16.4 Johnson & Johnson Rare Disease Drug Products Offered
10.16.5 Johnson & Johnson Recent Development
10.17 Biogen, Inc.
10.17.1 Biogen, Inc. Company Information
10.17.2 Biogen, Inc. Introduction and Business Overview
10.17.3 Biogen, Inc. Rare Disease Drug Sales, Revenue and Gross Margin (2018-2024)
10.17.4 Biogen, Inc. Rare Disease Drug Products Offered
10.17.5 Biogen, Inc. Recent Development
10.18 Takeda
10.18.1 Takeda Company Information
10.18.2 Takeda Introduction and Business Overview
10.18.3 Takeda Rare Disease Drug Sales, Revenue and Gross Margin (2018-2024)
10.18.4 Takeda Rare Disease Drug Products Offered
10.18.5 Takeda Recent Development
10.19 Amgen, Inc.
10.19.1 Amgen, Inc. Company Information
10.19.2 Amgen, Inc. Introduction and Business Overview
10.19.3 Amgen, Inc. Rare Disease Drug Sales, Revenue and Gross Margin (2018-2024)
10.19.4 Amgen, Inc. Rare Disease Drug Products Offered
10.19.5 Amgen, Inc. Recent Development
10.20 Deciphera
10.20.1 Deciphera Company Information
10.20.2 Deciphera Introduction and Business Overview
10.20.3 Deciphera Rare Disease Drug Sales, Revenue and Gross Margin (2018-2024)
10.20.4 Deciphera Rare Disease Drug Products Offered
10.20.5 Deciphera Recent Development
10.21 Atara Biotherapeutics
10.21.1 Atara Biotherapeutics Company Information
10.21.2 Atara Biotherapeutics Introduction and Business Overview
10.21.3 Atara Biotherapeutics Rare Disease Drug Sales, Revenue and Gross Margin (2018-2024)
10.21.4 Atara Biotherapeutics Rare Disease Drug Products Offered
10.21.5 Atara Biotherapeutics Recent Development
10.22 ProQR
10.22.1 ProQR Company Information
10.22.2 ProQR Introduction and Business Overview
10.22.3 ProQR Rare Disease Drug Sales, Revenue and Gross Margin (2018-2024)
10.22.4 ProQR Rare Disease Drug Products Offered
10.22.5 ProQR Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Rare Disease Drug Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Rare Disease Drug Industrial Chain Analysis
11.4 Rare Disease Drug Market Dynamics
11.4.1 Rare Disease Drug Industry Trends
11.4.2 Rare Disease Drug Market Drivers
11.4.3 Rare Disease Drug Market Challenges
11.4.4 Rare Disease Drug Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Rare Disease Drug Distributors
12.3 Rare Disease Drug Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Above 1‰
Table 2. Major Company of 0.65‰～1‰
Table 3. Major Company of Below 0.1‰
Table 4. Global Rare Disease Drug Sales by Type 2018 VS 2022 VS 2034 (US$ Million)
Table 5. Global Rare Disease Drug Sales by Type (2018-2024) & (K Doses)
Table 6. Global Rare Disease Drug Sales Market Share in Volume by Type (2018-2024)
Table 7. Global Rare Disease Drug Sales by Type (2018-2024) & (US& Million)
Table 8. Global Rare Disease Drug Market Share in Value by Type (2018-2024)
Table 9. Global Rare Disease Drug Price by Type (2018-2024) & (USD/Dose)
Table 10. Global Rare Disease Drug Sales by Type (2024-2034) & (K Doses)
Table 11. Global Rare Disease Drug Sales Market Share in Volume by Type (2024-2034)
Table 12. Global Rare Disease Drug Sales by Type (2024-2034) & (US$ Million)
Table 13. Global Rare Disease Drug Sales Market Share in Value by Type (2024-2034)
Table 14. Global Rare Disease Drug Price by Type (2024-2034) & (USD/Dose)
Table 15. North America Rare Disease Drug Sales by Type (2018-2024) & (K Doses)
Table 16. North America Rare Disease Drug Sales by Type (2018-2024) & (US$ Million)
Table 17. Europe Rare Disease Drug Sales (K Doses) by Type (2018-2024)
Table 18. Europe Rare Disease Drug Sales by Type (2018-2024) & (US$ Million)
Table 19. Asia-Pacific Rare Disease Drug Sales (K Doses) by Type (2018-2024)
Table 20. Asia-Pacific Rare Disease Drug Sales by Type (2018-2024) & (US$ Million)
Table 21. Latin America Rare Disease Drug Sales (K Doses) by Type (2018-2024)
Table 22. Latin America Rare Disease Drug Sales by Type (2018-2024) & (US$ Million)
Table 23. Middle East and Africa Rare Disease Drug Sales (K Doses) by Type (2018-2024)
Table 24. Middle East and Africa Rare Disease Drug Sales by Type (2018-2024) & (US$ Million)
Table 25. Global Rare Disease Drug Sales by Company (2018-2024) & (K Doses)
Table 26. Global Rare Disease Drug Sales Share by Company (2018-2024)
Table 27. Global Rare Disease Drug Revenue by Company (2018-2024) & (US$ Million)
Table 28. Global Rare Disease Drug Revenue Share by Company (2018-2024)
Table 29. Global Market Rare Disease Drug Price by Company (2018-2024) & (USD/Dose)
Table 30. Global Rare Disease Drug Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 31. Global Rare Disease Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 32. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Rare Disease Drug as of 2022)
Table 33. Date of Key Manufacturers Enter into Rare Disease Drug Market
Table 34. Key Manufacturers Rare Disease Drug Product Type
Table 35. Mergers & Acquisitions, Expansion Plans
Table 36. Global Rare Disease Drug Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2034
Table 37. Global Rare Disease Drug Sales by Region (2018-2024) & (K Doses)
Table 38. Global Rare Disease Drug Sales Market Share in Volume by Region (2018-2024)
Table 39. Global Rare Disease Drug Sales by Region (2018-2024) & (US$ Million)
Table 40. Global Rare Disease Drug Sales Market Share in Value by Region (2018-2024)
Table 41. Global Rare Disease Drug Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2018-2024)
Table 42. Global Rare Disease Drug Sales by Region (2024-2034) & (K Doses)
Table 43. Global Rare Disease Drug Sales Market Share in Volume by Region (2024-2034)
Table 44. Global Rare Disease Drug Sales by Region (2024-2034) & (US$ Million)
Table 45. Global Rare Disease Drug Sales Market Share in Value by Region (2024-2034)
Table 46. Global Rare Disease Drug Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2024-2034)
Table 47. Global Rare Disease Drug Sales by Application: 2018 VS 2022 VS 2034 (US$ Million)
Table 48. Global Rare Disease Drug Sales by Application (2018-2024) & (K Doses)
Table 49. Global Rare Disease Drug Sales Market Share in Volume by Application (2018-2024)
Table 50. Global Rare Disease Drug Sales by Application (2018-2024) & (US$ Million)
Table 51. Global Rare Disease Drug Sales Market Share in Value by Application (2018-2024)
Table 52. Global Rare Disease Drug Price by Application (2018-2024) & (USD/Dose)
Table 53. Global Rare Disease Drug Sales by Application (2024-2034) & (K Doses)
Table 54. Global Rare Disease Drug Sales Market Share in Volume by Application (2024-2034)
Table 55. Global Rare Disease Drug Sales by Application (2024-2034) & (US$ Million)
Table 56. Global Rare Disease Drug Sales Market Share in Value by Application (2024-2034)
Table 57. Global Rare Disease Drug Price by Application (2024-2034) & (USD/Dose)
Table 58. North America Rare Disease Drug Sales by Application (2018-2024) (K Doses)
Table 59. North America Rare Disease Drug Sales by Application (2018-2024) & (US$ Million)
Table 60. Europe Rare Disease Drug Sales by Application (2018-2024) (K Doses)
Table 61. Europe Rare Disease Drug Sales by Application (2018-2024) & (US$ Million)
Table 62. Asia-Pacific Rare Disease Drug Sales by Application (2018-2024) (K Doses)
Table 63. Asia-Pacific Rare Disease Drug Sales by Application (2018-2024) & (US$ Million)
Table 64. Latin America Rare Disease Drug Sales by Application (2018-2024) (K Doses)
Table 65. Latin America Rare Disease Drug Sales by Application (2018-2024) & (US$ Million)
Table 66. Middle East and Africa Rare Disease Drug Sales by Application (2018-2024) (K Doses)
Table 67. Middle East and Africa Rare Disease Drug Sales by Application (2018-2024) & (US$ Million)
Table 68. North America Rare Disease Drug Sales by Country (2018-2024) & (K Doses)
Table 69. North America Rare Disease Drug Sales Market Share in Volume by Country (2018-2024)
Table 70. North America Rare Disease Drug Sales by Country (2018-2024) & (US$ Million)
Table 71. North America Rare Disease Drug Sales Market Share in Value by Country (2018-2024)
Table 72. North America Rare Disease Drug Sales by Country (2024-2034) & (K Doses)
Table 73. North America Rare Disease Drug Sales Market Share in Volume by Country (2024-2034)
Table 74. North America Rare Disease Drug Sales by Country (2024-2034) & (US$ Million)
Table 75. North America Rare Disease Drug Sales Market Share in Value by Country (2024-2034)
Table 76. Europe Rare Disease Drug Sales by Country (2018-2024) & (K Doses)
Table 77. Europe Rare Disease Drug Sales Market Share in Volume by Country (2018-2024)
Table 78. Europe Rare Disease Drug Sales by Country (2018-2024) & (US$ Million)
Table 79. Europe Rare Disease Drug Sales Market Share in Value by Country (2018-2024)
Table 80. Europe Rare Disease Drug Sales by Country (2024-2034) & (K Doses)
Table 81. Europe Rare Disease Drug Sales Market Share in Volume by Country (2024-2034)
Table 82. Europe Rare Disease Drug Sales by Country (2024-2034) & (US$ Million)
Table 83. Europe Rare Disease Drug Sales Market Share in Value by Country (2024-2034)
Table 84. Asia-Pacific Rare Disease Drug Sales by Region (2018-2024) & (K Doses)
Table 85. Asia-Pacific Rare Disease Drug Sales Market Share in Volume by Region (2018-2024)
Table 86. Asia-Pacific Rare Disease Drug Sales by Region (2018-2024) & (US$ Million)
Table 87. Asia-Pacific Rare Disease Drug Sales Market Share in Value by Region (2018-2024)
Table 88. Asia-Pacific Rare Disease Drug Sales by Region (2024-2034) & (K Doses)
Table 89. Asia-Pacific Rare Disease Drug Sales Market Share in Volume by Region (2024-2034)
Table 90. Asia-Pacific Rare Disease Drug Sales by Region (2024-2034) & (US$ Million)
Table 91. Asia-Pacific Rare Disease Drug Sales Market Share in Value by Region (2024-2034)
Table 92. Latin America Rare Disease Drug Sales by Country (2018-2024) & (K Doses)
Table 93. Latin America Rare Disease Drug Sales Market Share in Volume by Country (2018-2024)
Table 94. Latin America Rare Disease Drug Sales by Country (2018-2024) & (US$ Million)
Table 95. Latin America Rare Disease Drug Sales Market Share in Value by Country (2018-2024)
Table 96. Latin America Rare Disease Drug Sales by Country (2024-2034) & (K Doses)
Table 97. Latin America Rare Disease Drug Sales Market Share in Volume by Country (2024-2034)
Table 98. Latin America Rare Disease Drug Sales by Country (2024-2034) & (US$ Million)
Table 99. Latin America Rare Disease Drug Sales Market Share in Value by Country (2024-2034)
Table 100. Middle East and Africa Rare Disease Drug Sales by Country (2018-2024) & (K Doses)
Table 101. Middle East and Africa Rare Disease Drug Sales Market Share in Volume by Country (2018-2024)
Table 102. Middle East and Africa Rare Disease Drug Sales by Country (2018-2024) & (US$ Million)
Table 103. Middle East and Africa Rare Disease Drug Sales Market Share in Value by Country (2018-2024)
Table 104. Middle East and Africa Rare Disease Drug Sales by Country (2024-2034) & (K Doses)
Table 105. Middle East and Africa Rare Disease Drug Sales Market Share in Volume by Country (2024-2034)
Table 106. Middle East and Africa Rare Disease Drug Sales by Country (2024-2034) & (US$ Million)
Table 107. Middle East and Africa Rare Disease Drug Sales Market Share in Value by Country (2024-2034)
Table 108. Novartis AG Company Information
Table 109. Novartis AG Introduction and Business Overview
Table 110. Novartis AG Rare Disease Drug Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2018-2024)
Table 111. Novartis AG Rare Disease Drug Product
Table 112. Novartis AG Recent Development
Table 113. Bristol-Myers Squibb Company Company Information
Table 114. Bristol-Myers Squibb Company Introduction and Business Overview
Table 115. Bristol-Myers Squibb Company Rare Disease Drug Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2018-2024)
Table 116. Bristol-Myers Squibb Company Rare Disease Drug Product
Table 117. Bristol-Myers Squibb Company Recent Development
Table 118. Celgene Corporation Company Information
Table 119. Celgene Corporation Introduction and Business Overview
Table 120. Celgene Corporation Rare Disease Drug Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2018-2024)
Table 121. Celgene Corporation Rare Disease Drug Product
Table 122. Celgene Corporation Recent Development
Table 123. F. Hoffmann-La Roche Ltd. Company Information
Table 124. F. Hoffmann-La Roche Ltd. Introduction and Business Overview
Table 125. F. Hoffmann-La Roche Ltd. Rare Disease Drug Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2018-2024)
Table 126. F. Hoffmann-La Roche Ltd. Rare Disease Drug Product
Table 127. F. Hoffmann-La Roche Ltd. Recent Development
Table 128. Pfizer, Inc. Company Information
Table 129. Pfizer, Inc. Introduction and Business Overview
Table 130. Pfizer, Inc. Rare Disease Drug Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2018-2024)
Table 131. Pfizer, Inc. Rare Disease Drug Product
Table 132. Pfizer, Inc. Recent Development
Table 133. Sanofi S.A. Company Information
Table 134. Sanofi S.A. Introduction and Business Overview
Table 135. Sanofi S.A. Rare Disease Drug Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2018-2024)
Table 136. Sanofi S.A. Rare Disease Drug Product
Table 137. Sanofi S.A. Recent Development
Table 138. Alexion Pharmaceuticals, Inc. Company Information
Table 139. Alexion Pharmaceuticals, Inc. Introduction and Business Overview
Table 140. Alexion Pharmaceuticals, Inc. Rare Disease Drug Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2018-2024)
Table 141. Alexion Pharmaceuticals, Inc. Rare Disease Drug Product
Table 142. Alexion Pharmaceuticals, Inc. Recent Development
Table 143. Eli Lilly and Company Company Information
Table 144. Eli Lilly and Company Introduction and Business Overview
Table 145. Eli Lilly and Company Rare Disease Drug Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2018-2024)
Table 146. Eli Lilly and Company Rare Disease Drug Product
Table 147. Eli Lilly and Company Recent Development
Table 148. Novo Nordisk A/S Company Information
Table 149. Novo Nordisk A/S Introduction and Business Overview
Table 150. Novo Nordisk A/S Rare Disease Drug Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2018-2024)
Table 151. Novo Nordisk A/S Rare Disease Drug Product
Table 152. Novo Nordisk A/S Recent Development
Table 153. AstraZeneca Company Information
Table 154. AstraZeneca Introduction and Business Overview
Table 155. AstraZeneca Rare Disease Drug Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2018-2024)
Table 156. AstraZeneca Rare Disease Drug Product
Table 157. AstraZeneca Recent Development
Table 158. Eisai Co., Ltd. Company Information
Table 159. Eisai Co., Ltd. Introduction and Business Overview
Table 160. Eisai Co., Ltd. Rare Disease Drug Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2018-2024)
Table 161. Eisai Co., Ltd. Rare Disease Drug Product
Table 162. Eisai Co., Ltd. Recent Development
Table 163. Daiichi Sankyo Company Limited Company Information
Table 164. Daiichi Sankyo Company Limited Introduction and Business Overview
Table 165. Daiichi Sankyo Company Limited Rare Disease Drug Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2018-2024)
Table 166. Daiichi Sankyo Company Limited Rare Disease Drug Product
Table 167. Daiichi Sankyo Company Limited Recent Development
Table 168. Bayer AG Company Information
Table 169. Bayer AG Introduction and Business Overview
Table 170. Bayer AG Rare Disease Drug Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2018-2024)
Table 171. Bayer AG Rare Disease Drug Product
Table 172. Bayer AG Recent Development
Table 173. GlaxoSmithKline Company Information
Table 174. GlaxoSmithKline Introduction and Business Overview
Table 175. GlaxoSmithKline Rare Disease Drug Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2018-2024)
Table 176. GlaxoSmithKline Rare Disease Drug Product
Table 177. GlaxoSmithKline Recent Development
Table 178. Merck & Co., Inc. Company Information
Table 179. Merck & Co., Inc. Introduction and Business Overview
Table 180. Merck & Co., Inc. Rare Disease Drug Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2018-2024)
Table 181. Merck & Co., Inc. Rare Disease Drug Product
Table 182. Merck & Co., Inc. Recent Development
Table 183. Johnson & Johnson Company Information
Table 184. Johnson & Johnson Introduction and Business Overview
Table 185. Johnson & Johnson Rare Disease Drug Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2018-2024)
Table 186. Johnson & Johnson Rare Disease Drug Product
Table 187. Johnson & Johnson Recent Development
Table 188. Biogen, Inc. Company Information
Table 189. Biogen, Inc. Introduction and Business Overview
Table 190. Biogen, Inc. Rare Disease Drug Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2018-2024)
Table 191. Biogen, Inc. Rare Disease Drug Product
Table 192. Biogen, Inc. Recent Development
Table 193. Takeda Company Information
Table 194. Takeda Introduction and Business Overview
Table 195. Takeda Rare Disease Drug Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2018-2024)
Table 196. Takeda Rare Disease Drug Product
Table 197. Takeda Recent Development
Table 198. Amgen, Inc. Company Information
Table 199. Amgen, Inc. Introduction and Business Overview
Table 200. Amgen, Inc. Rare Disease Drug Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2018-2024)
Table 201. Amgen, Inc. Rare Disease Drug Product
Table 202. Amgen, Inc. Recent Development
Table 203. Deciphera Company Information
Table 204. Deciphera Introduction and Business Overview
Table 205. Deciphera Rare Disease Drug Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2018-2024)
Table 206. Deciphera Rare Disease Drug Product
Table 207. Deciphera Recent Development
Table 208. Atara Biotherapeutics Company Information
Table 209. Atara Biotherapeutics Introduction and Business Overview
Table 210. Atara Biotherapeutics Rare Disease Drug Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2018-2024)
Table 211. Atara Biotherapeutics Rare Disease Drug Product
Table 212. Atara Biotherapeutics Recent Development
Table 213. ProQR Company Information
Table 214. ProQR Introduction and Business Overview
Table 215. ProQR Rare Disease Drug Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2018-2024)
Table 216. ProQR Rare Disease Drug Product
Table 217. ProQR Recent Development
Table 218. Key Raw Materials Lists
Table 219. Raw Materials Key Suppliers Lists
Table 220. Rare Disease Drug Market Trends
Table 221. Rare Disease Drug Market Drivers
Table 222. Rare Disease Drug Market Challenges
Table 223. Rare Disease Drug Market Restraints
Table 224. Rare Disease Drug Distributors List
Table 225. Rare Disease Drug Downstream Customers
Table 226. Research Programs/Design for This Report
Table 227. Key Data Information from Secondary Sources
Table 228. Key Data Information from Primary Sources
List of Figures
Figure 1. Rare Disease Drug Product Picture
Figure 2. Global Rare Disease Drug Market Size, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Rare Disease Drug Market Size Status and Outlook (2018-2034) & (US$ Million)
Figure 4. Global Rare Disease Drug Sales Status and Outlook (2018-2034) & (K Doses)
Figure 5. Product Picture of Above 1‰
Figure 6. Global Above 1‰ Sales YoY Growth (2018-2034) & (K Doses)
Figure 7. Product Picture of 0.65‰～1‰
Figure 8. Global 0.65‰～1‰ Sales YoY Growth (2018-2034) & (K Doses)
Figure 9. Product Picture of Below 0.1‰
Figure 10. Global Below 0.1‰ Sales YoY Growth (2018-2034) & (K Doses)
Figure 11. Global Rare Disease Drug Sales by Type (2018-2034) & (US$ Million)
Figure 12. Global Rare Disease Drug Sales Market Share by Type in 2022 & 2034
Figure 13. North America Rare Disease Drug Sales Market Share in Volume by Type in 2022
Figure 14. North America Rare Disease Drug Sales Market Share in Value by Type in 2022
Figure 15. Europe Rare Disease Drug Sales Market Share in Volume by Type in 2022
Figure 16. Europe Rare Disease Drug Sales Market Share in Value by Type in 2022
Figure 17. Asia-Pacific Rare Disease Drug Sales Market Share in Volume by Type in 2022
Figure 18. Asia-Pacific Rare Disease Drug Sales Market Share in Value by Type in 2022
Figure 19. Latin America Rare Disease Drug Sales Market Share in Volume by Type in 2022
Figure 20. Latin America Rare Disease Drug Sales Market Share in Value by Type in 2022
Figure 21. Middle East and Africa Rare Disease Drug Sales Market Share in Volume by Type in 2022
Figure 22. Middle East and Africa Rare Disease Drug Sales Market Share in Value by Type in 2022
Figure 23. The 5 and 10 Largest Manufacturers in the World: Market Share by Rare Disease Drug Sales in 2022
Figure 24. The 5 and 10 Largest Manufacturers in the World: Market Share by Rare Disease Drug Revenue in 2022
Figure 25. Rare Disease Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 26. Product Picture of Hospital Pharmacies
Figure 27. Global Hospital Pharmacies Sales YoY Growth (2018-2034) & (K Doses)
Figure 28. Product Picture of Speciality Pharmacies
Figure 29. Global Speciality Pharmacies Sales YoY Growth (2018-2034) & (K Doses)
Figure 30. Product Picture of Retail pharmacies
Figure 31. Global Retail pharmacies Sales YoY Growth (2018-2034) & (K Doses)
Figure 32. Product Picture of Others
Figure 33. Global Others Sales YoY Growth (2018-2034) & (K Doses)
Figure 34. Global Rare Disease Drug Sales by Application (2018-2034) & (US$ Million)
Figure 35. Global Rare Disease Drug Sales Market Share by Application in 2022 & 2034
Figure 36. North America Rare Disease Drug Sales Market Share in Volume by Application in 2022
Figure 37. North America Rare Disease Drug Sales Market Share in Value by Application in 2022
Figure 38. Europe Rare Disease Drug Sales Market Share in Volume by Application in 2022
Figure 39. Europe Rare Disease Drug Sales Market Share in Value by Application in 2022
Figure 40. Asia-Pacific Rare Disease Drug Sales Market Share in Volume by Application in 2022
Figure 41. Asia-Pacific Rare Disease Drug Sales Market Share in Value by Application in 2022
Figure 42. Latin America Rare Disease Drug Sales Market Share in Volume by Application in 2022
Figure 43. Latin America Rare Disease Drug Sales Market Share in Value by Application in 2022
Figure 44. Middle East and Africa Rare Disease Drug Sales Market Share in Value by Application in 2022
Figure 45. Key Raw Materials Price
Figure 46. Rare Disease Drug Manufacturing Cost Structure
Figure 47. Rare Disease Drug Industrial Chain Analysis
Figure 48. Channels of Distribution
Figure 49. Distributors Profiles
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries